Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2015-07-27
DOI
10.1155/2015/672759
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
- (2014) Yi Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
- (2014) Jian-Ya Zhou et al. CANCER LETTERS
- The TGF -miR200-MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
- (2014) E. Izumchenko et al. CANCER RESEARCH
- Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers
- (2014) F. Xu et al. Clinical & Translational Oncology
- Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
- (2014) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Exploring microRNA-mediated alteration of EGFR signaling pathway in non-small cell lung cancer using an mRNA:miRNA regression model supported by target prediction databases
- (2014) Fengfeng Wang et al. GENOMICS
- Unique microRNA-profiles inEGFR-mutated lung adenocarcinomas
- (2014) Maria Moksnes Bjaanaes et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma
- (2014) HIROKO MATAKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
- (2014) Yi-Long Wu et al. LANCET ONCOLOGY
- Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR-145 through the ERK1/2 in non-small cell lung cancer
- (2014) YUE-HUI GUO et al. ONCOLOGY REPORTS
- Restoration of miR-7 expression suppresses the growth of Lewis lung cancer cells by modulating epidermal growth factor receptor signaling
- (2014) JINGRONG LI et al. ONCOLOGY REPORTS
- MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance
- (2014) Chang Gong Lee et al. PLoS One
- MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma
- (2014) Lu-Kai Wang et al. PLoS One
- Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer
- (2014) Y Wang et al. Cell Death & Disease
- Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins
- (2013) J. Remon et al. CANCER TREATMENT REVIEWS
- A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population
- (2013) Hyo-Sung Jeon et al. GENE
- NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition
- (2013) Robert M. Mader et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling
- (2013) W. W. Du et al. JOURNAL OF CELL SCIENCE
- Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
- (2013) Aamir Ahmad et al. Journal of Hematology & Oncology
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation
- (2013) Yi Shen et al. MEDICAL ONCOLOGY
- MiR-134/487b/655 Cluster Regulates TGF- -Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
- (2013) K. Kitamura et al. MOLECULAR CANCER THERAPEUTICS
- miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
- (2013) Gang Chen et al. PLoS One
- Circulating MicroRNAs in Relation to EGFR Status and Survival of Lung Adenocarcinoma in Female Non-Smokers
- (2013) Huan Zhang et al. PLoS One
- Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2
- (2013) M. Acunzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression
- (2013) W Wang et al. Cell Death & Disease
- Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
- (2013) Sílvia Cufí et al. Scientific Reports
- A view on EGFR-targeted therapies from the oncogene-addiction perspective
- (2013) Rolando Perez et al. Frontiers in Pharmacology
- Isolation of miRNAs that target EGFR mRNA in human lung cancer
- (2012) Gaku Yamaguchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence
- (2012) H Salim et al. BRITISH JOURNAL OF CANCER
- Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
- (2012) Lawrence WC Chan et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Monoclonal antibodies in lung cancer
- (2012) Yujiong Wang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Targeting signaling pathways in lung cancer therapy
- (2012) William CS Cho EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor
- (2012) Lingxiang Liu et al. FEBS Journal
- The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells
- (2012) ZHE ZHANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
- (2012) Kang-Yi Su et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- MicroRNAs in cancer diagnosis and therapy: from bench to bedside
- (2012) Isamu Hoshino et al. SURGERY TODAY
- microRNAs: Master Regulators as Potential Therapeutics in Cancer
- (2011) Michela Garofalo et al. Annual Review of Pharmacology and Toxicology
- A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
- (2011) J L Bryant et al. BRITISH JOURNAL OF CANCER
- Targeted Therapies for Lung Cancer
- (2011) Jill E. Larsen et al. CANCER JOURNAL
- Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer
- (2011) I. S. Donev et al. CLINICAL CANCER RESEARCH
- Liposomal Delivery of MicroRNA-7-Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells
- (2011) K. Rai et al. MOLECULAR CANCER THERAPEUTICS
- EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
- (2011) Michela Garofalo et al. NATURE MEDICINE
- Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
- (2011) G Mudduluru et al. ONCOGENE
- MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer
- (2011) Bin Xu et al. PROSTATE
- MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
- (2011) William CS Cho et al. RNA Biology
- Targeting epidermal growth factor receptor: Central signaling kinase in lung cancer
- (2010) Takeshi Yoshida et al. BIOCHEMICAL PHARMACOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-146b-5p Suppresses EGFR Expression and ReducesIn VitroMigration and Invasion of Glioma
- (2010) Mark Katakowski et al. CANCER INVESTIGATION
- EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF
- (2010) Y.-T. Chou et al. CANCER RESEARCH
- MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer
- (2010) Miao Zhong et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
- (2010) Xuan Zhou et al. LABORATORY INVESTIGATION
- miRNA expression profiling of lung adenocarcinomas: correlation with mutational status
- (2010) Sanja Dacic et al. MODERN PATHOLOGY
- MicroRNA control of signal transduction
- (2010) Masafumi Inui et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
- (2009) L. Adam et al. CLINICAL CANCER RESEARCH
- Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma
- (2009) K. Politi et al. Disease Models & Mechanisms
- MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
- (2009) William C.S. Cho INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
- (2009) M. Seike et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR regulation by microRNA in lung cancer: a rose by any other name ... is an increasingly complicated rose
- (2008) D. N. Hayes et al. ANNALS OF ONCOLOGY
- EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
- (2008) G. J. Weiss et al. ANNALS OF ONCOLOGY
- microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma
- (2008) B. Kefas et al. CANCER RESEARCH
- Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
- (2008) Rebecca J. Webster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGFR-targeted therapies in lung cancer: predictors of response and toxicity
- (2008) Rebecca Suk Heist et al. PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started